CSF replication reduced with Sustiva.
D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D048588:Benzoxazines; D002555:Cerebrospinal Fluid / Q000821:virology*; D003521:Cyclopropanes; D015658:HIV Infections / Q000134:cerebrospinal fluid / Q000188:drug therapy; D015497:HIV-1 / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D010078:Oxazines / Q000627:therapeutic use*; D012367:RNA, Viral / Q000134:cerebrospinal fluid* / Q000187:drug effects
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D012367:RNA, Viral; C098320:efavirenz